KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Other Accumulated Expenses (2020 - 2023)

Historic Other Accumulated Expenses for Cvs Health (CVS) over the last 4 years, with Q3 2023 value amounting to $12.6 billion.

  • Cvs Health's Other Accumulated Expenses rose 2124.43% to $12.6 billion in Q3 2023 from the same period last year, while for Sep 2023 it was $12.6 billion, marking a year-over-year increase of 2124.43%. This contributed to the annual value of $10.1 billion for FY2022, which is 1687.02% up from last year.
  • As of Q3 2023, Cvs Health's Other Accumulated Expenses stood at $12.6 billion, which was up 2124.43% from $12.0 billion recorded in Q2 2023.
  • Cvs Health's Other Accumulated Expenses' 5-year high stood at $12.6 billion during Q3 2023, with a 5-year trough of $7.9 billion in Q4 2020.
  • Over the past 4 years, Cvs Health's median Other Accumulated Expenses value was $10.2 billion (recorded in 2022), while the average stood at $10.2 billion.
  • As far as peak fluctuations go, Cvs Health's Other Accumulated Expenses soared by 934.98% in 2021, and later surged by 2124.43% in 2023.
  • Over the past 4 years, Cvs Health's Other Accumulated Expenses (Quarter) stood at $7.9 billion in 2020, then rose by 9.35% to $8.7 billion in 2021, then increased by 16.87% to $10.1 billion in 2022, then increased by 23.74% to $12.6 billion in 2023.
  • Its Other Accumulated Expenses stands at $12.6 billion for Q3 2023, versus $12.0 billion for Q2 2023 and $10.9 billion for Q1 2023.